Introduction: optimizing outcomes through pharmaceutical advances in the treatment of chronic myeloid leukemia.
Frame
David
D
University of Michigan Health System, Ann Arbor, MI, USA.
D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D016896:Treatment Outcome